Cargando…
Telepharmacy during COVID-19: A Scoping Review
The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628897/ https://www.ncbi.nlm.nih.gov/pubmed/34842823 http://dx.doi.org/10.3390/pharmacy9040183 |
_version_ | 1784607091581779968 |
---|---|
author | Unni, Elizabeth J. Patel, Kanchita Beazer, Isaac Rex Hung, Man |
author_facet | Unni, Elizabeth J. Patel, Kanchita Beazer, Isaac Rex Hung, Man |
author_sort | Unni, Elizabeth J. |
collection | PubMed |
description | The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced when implementing telehealth initiatives? (3) what were the strategies used by pharmacies to overcome the challenges, and (4) what were some of the innovative methods used by pharmacies to implement telepharmacy? A literature search was conducted to include publications post-March 2020 about telepharmacy implementation via PubMed Central database and Google searches. All articles were examined for inclusion or exclusion based on pre-determined criteria. A total of 33 articles were reviewed. The most commonly observed telepharmacy initiatives were virtual consultations, home delivery of medicines and patient education. Limited access to technology and lack of digital access and literacy were major barriers in the implementation of telepharmacy. New protocols were developed by healthcare systems and regulations were relaxed by countries to accommodate telepharmacy. Pharmacies that successfully implemented telepharmacy overcame these challenges through patient and pharmacist education. The review also revealed the steps that can be taken by pharmacy organizations, payers and entrepreneurs in leveraging the convenience of telepharmacy. |
format | Online Article Text |
id | pubmed-8628897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86288972021-11-30 Telepharmacy during COVID-19: A Scoping Review Unni, Elizabeth J. Patel, Kanchita Beazer, Isaac Rex Hung, Man Pharmacy (Basel) Review The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced when implementing telehealth initiatives? (3) what were the strategies used by pharmacies to overcome the challenges, and (4) what were some of the innovative methods used by pharmacies to implement telepharmacy? A literature search was conducted to include publications post-March 2020 about telepharmacy implementation via PubMed Central database and Google searches. All articles were examined for inclusion or exclusion based on pre-determined criteria. A total of 33 articles were reviewed. The most commonly observed telepharmacy initiatives were virtual consultations, home delivery of medicines and patient education. Limited access to technology and lack of digital access and literacy were major barriers in the implementation of telepharmacy. New protocols were developed by healthcare systems and regulations were relaxed by countries to accommodate telepharmacy. Pharmacies that successfully implemented telepharmacy overcame these challenges through patient and pharmacist education. The review also revealed the steps that can be taken by pharmacy organizations, payers and entrepreneurs in leveraging the convenience of telepharmacy. MDPI 2021-11-11 /pmc/articles/PMC8628897/ /pubmed/34842823 http://dx.doi.org/10.3390/pharmacy9040183 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Unni, Elizabeth J. Patel, Kanchita Beazer, Isaac Rex Hung, Man Telepharmacy during COVID-19: A Scoping Review |
title | Telepharmacy during COVID-19: A Scoping Review |
title_full | Telepharmacy during COVID-19: A Scoping Review |
title_fullStr | Telepharmacy during COVID-19: A Scoping Review |
title_full_unstemmed | Telepharmacy during COVID-19: A Scoping Review |
title_short | Telepharmacy during COVID-19: A Scoping Review |
title_sort | telepharmacy during covid-19: a scoping review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628897/ https://www.ncbi.nlm.nih.gov/pubmed/34842823 http://dx.doi.org/10.3390/pharmacy9040183 |
work_keys_str_mv | AT unnielizabethj telepharmacyduringcovid19ascopingreview AT patelkanchita telepharmacyduringcovid19ascopingreview AT beazerisaacrex telepharmacyduringcovid19ascopingreview AT hungman telepharmacyduringcovid19ascopingreview |